APGE   $86.27  -0.29% Market Closed After Close 86.0 -0.31%

Apogee Therapeutics, Inc.
Total Cash 676.23M
totalCashPerShare 11.562
EBITDA
Total Debt 4.08M
quickRatio 27.47
currentRatio 27.698
Total Revenue
debtToEquity 0.528
Revenue/Share
ROA -0.19296
ROE -0.26725
grossProfits
freeCashflow -71.46M
operatingCashflow -110.57M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 2.51B
forwardPE -14.339475
floatShares 29.05M
sharesOutstanding 43.19M
sharesShort 6.87M
sharesShortPriorMonth 8.19M
dateShortInterest
sharesPercentSharesOut 0.12%
heldPercentInsiders 0.11%
heldPercentInstitutions 1.27%
Short Ratio help_outline 14.72%
shortPercentOfFloat 0.18%
impliedSharesOutstanding
bookValue 13.229
Price To Book help_outline 4.12
earningsQuarterlyGrowth
netIncomeToCommon -118.48M
trailingEps -2.09%
forwardEps -3.80%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.77 3Q 2024
institutionsCount 209
lastUpdated Nov. 2, 2024, 6:29 a.m.